Hydrocodone Bitartrate / Potassium Guaiacolsulfonate
Pronunciation: (hye-droe-KOE-done bye-TAR-trate/po-TAS-ee-um GWYE-a-klo-sul-FON-ate)Class: Upper respiratory combination
Trade Names
Entuss Expectorant
- Liquid 5 mg Hydrocodone Bitartrate/300 mg Potassium Guaiacolsulfonate per 5 mL
Hydron EX
- Liquid 2.5 mg Hydrocodone Bitartrate/120 mg Potassium Guaiacolsulfonate per 5 mL
Hydron KGS
- Liquid 5 mg Hydrocodone Bitartrate/300 mg Potassium Guaiacolsulfonate per 5 mL
Jaycof CIII Expectorant
- Liquid 5 mg Hydrocodone Bitartrate/350 mg Potassium Guaiacolsulfonate per 5 mL
M-Clear
- Liquid 5 mg Hydrocodone Bitartrate/400 mg Potassium Guaiacolsulfonate per 5 mL
Marcof Expectorant
- Liquid 5 mg Hydrocodone Bitartrate/350 mg Potassium Guaiacolsulfonate per 5 mL
MC Cough Syrup
- Liquid 5 mg Hydrocodone Bitartrate/400 mg Potassium Guaiacolsulfonate per 5 mL
MCJR Cough Syrup
- Liquid 2.5 mg Hydrocodone Bitartrate/175 mg Potassium Guaiacolsulfonate per 5 mL
Mintuss NX
- Liquid 3 mg Hydrocodone Bitartrate/150 mg Potassium Guaiacolsulfonate per 5 mL
Pro-Clear Antitussive/Expectorant
- Liquid 3 mg Hydrocodone Bitartrate/350 mg Potassium Guaiacolsulfonate per 5 mL
Prolex DH
- Liquid 4.5 mg Hydrocodone Bitartrate/300 mg Potassium Guaiacolsulfonate per 5 mL
Indications and Usage
Temporary relief of dry, nonproductive cough due to colds, pertussis, or influenza.
Contraindications
Hypersensitivity to any component of the product; hypersensitivity to opioids; intracranial lesion associated with increased intracranial pressure; depressed ventilatory function.
Dosage and Administration
Adults and Children 12 yr of age and olderPO
Entuss , Hydron KGS , Jaycof , Prolex DH5 to 7.5 mL up to 4 times daily.
Hydron EX , Mintuss NX10 to 15 mL every 4 to 6 h (max, 4 doses [60 mL] in 24 h).
M-Clear , MC Cough Syrup5 mL every 4 to 6 h (max, 30 mL in 24 h).
Marcof Expectorant5 mL after meals and at bedtime, at least 4 h apart (max, 30 mL in 24 h).
MCJR Cough Syrup5 to 10 mL up to 4 times daily.
Pro-Clear5 to 10 mL every 4 to 6 h (max, 4 doses in 24 h).
Children 6 to 12 yr of agePO
Entuss , Hydron KGS , Jaycof , MCJR Cough Syrup , Prolex DH2.5 to 5 mL up to 4 times daily.
Hydron EX5 to 10 mL every 4 to 6 h (max, 40 mL in 24 h).
M-Clear , MC Cough Syrup2.5 mL every 4 to 6 h (max, 15 mL in 24 h).
Marcof Expectorant2.5 mL after meals and at bedtime, at least 4 h apart (max, 15 mL in 24 h).
Mintuss NX5 to 7.5 mL every 4 to 6 h (max, 4 doses in 24 h).
Pro-Clear5 mL every 4 to 6 h (max, 4 doses in 24 h).
Children 3 to 6 yr of agePO
Entuss , Hydron KGS , Jaycof , MCJR Cough Syrup , Prolex DH1.25 to 2.5 mL up to 4 times daily.
Hydron EX (2 to 6 yr of age)2.5 to 5 mL every 4 to 6 h (max, 20 mL in 24 h).
Mintuss NX (2 to 6 yr of age)2.5 to 5 mL every 4 to 6 h (max, 4 doses in 24 h).
Pro-Clear (2 to 6 yr of age)2.5 mL every 4 to 6 h (max, 4 doses in 24 h).
General Advice
- Dose in children younger than 12 yr of age should be based on hydrocodone 0.6 mg/kg/day in equally divided doses, 4 times daily.
Storage/Stability
Store at 59° to 86°F.
Drug Interactions
General anesthetics, other narcotics, phenothiazines or other tranquilizers, sedative-hypnotics or other CNS depressantsAdditive CNS depression; dosage adjustments may be needed.
Laboratory Test Interactions
None well documented.
Adverse Reactions
Cardiovascular
Hypertension, palpitations, postural hypotension.
CNS
Anxiety, dizziness, drowsiness, dysphoria, fear, giddiness, impaired mental and physical performance, lassitude, lethargy, mental clouding, mood changes, psychic dependence, sedation.
EENT
Blurred vision.
GI
Constipation, nausea, vomiting.
Genitourinary
Spasm of vesical sphincters, ureteral spasm, urinary retention.
Respiratory
Dose-related respiratory depression.
Precautions
Pregnancy
Category C .
Lactation
Undetermined.
Children
Not recommended for use in children younger than 3 yr of age (2 yr of age for Hydron EX , Mintuss NX , and Pro-Clear ).
Marcof ExpectorantSafety and efficacy not established in children younger than 6 yr of age.
Acute abdominal conditions
Diagnosis may be obscured.
Dependence
Hydrocodone has abuse potential; may be habit-forming.
Head injury and increased intracranial pressure
Narcotic adverse reactions may obscure the clinical course of patients with head injuries; respiratory depression properties and the capacity of hydrocodone to elevate CSF pressure may be obscured.
Nonteratogenic effects
Babies born to mothers who have been taking hydrocodone regularly prior to delivery will be physically dependent.
Respiratory depression
Dose-related respiratory depression occurs.
Special risk patients
Use with caution in elderly or debilitated patients, and in those with hepatic or renal function impairment.
Overdosage
Symptoms
Apnea, bradycardia, cardiac arrest, circulatory collapse, cold and clammy skin, death, extreme somnolence progressing to stupor or coma, hypotension, respiratory depression, skeletal muscle flaccidity.
Patient Information
- Advise the patient that drug may cause drowsiness, or impaired judgment or thinking and to use caution while driving, riding a bike, or performing other tasks requiring alertness until tolerance is determined.
Copyright © 2009 Wolters Kluwer Health.
More Hydrocodone Bitartrate/Potassium Guaiacolsulfonate resources
- Hydrocodone Bitartrate/Potassium Guaiacolsulfonate Side Effects (in more detail)
- Hydrocodone Bitartrate/Potassium Guaiacolsulfonate Use in Pregnancy & Breastfeeding
- Hydrocodone Bitartrate/Potassium Guaiacolsulfonate Drug Interactions
- Hydrocodone Bitartrate/Potassium Guaiacolsulfonate Support Group
- 0 Reviews · Be the first to review/rate this drug

